[Advances on the treatment of Fusobacterium nucleatum -promoted colorectal cancers using nanomaterials].

() is an oral anaerobic bacterium that has recently been found to colonize on the surface of colorectal cancer cells in humans, and its degree of enrichment is highly negatively correlated with the prognosis of tumor treatment. Numerous studies have shown that is involved in the occurrence and development of colorectal cancer (CRC), and interacts with multiple components in the tumor microenvironment to increase tumor resistance. In recent years, researchers have begun using nanomedicine to inhibit 's proliferation at the tumor site or directly target to treat CRC. This review summarizes the mechanism of in promoting CRC and the latest research progress on -related CRC therapy using different nanomaterials. Finally, the applications perspective of nanomaterials in -promoted CRC therapy was prospected.